356 related articles for article (PubMed ID: 9837802)
21. Cyclosporine A inhibits the activity of a TATA box-binding protein that is required for transcription from the adenovirus major late promoter.
Mahajan PB; Thompson EA
J Biol Chem; 1993 Aug; 268(22):16693-8. PubMed ID: 8344948
[TBL] [Abstract][Full Text] [Related]
22. Molecular cloning and functional analysis of the human Na(+)/H(+) exchanger NHE3 promoter.
Malakooti J; Memark VC; Dudeja PK; Ramaswamy K
Am J Physiol Gastrointest Liver Physiol; 2002 Mar; 282(3):G491-500. PubMed ID: 11841999
[TBL] [Abstract][Full Text] [Related]
23. DNA topoisomerase I is involved in both repression and activation of transcription.
Merino A; Madden KR; Lane WS; Champoux JJ; Reinberg D
Nature; 1993 Sep; 365(6443):227-32. PubMed ID: 8396729
[TBL] [Abstract][Full Text] [Related]
24. Kinetic and mechanistic analysis of the RNA polymerase II transcrption reaction at the human interleukin-2 promoter.
Ferguson HA; Kugel JF; Goodrich JA
J Mol Biol; 2001 Dec; 314(5):993-1006. PubMed ID: 11743717
[TBL] [Abstract][Full Text] [Related]
25. CIF, an essential cofactor for TFIID-dependent initiator function.
Kaufmann J; Verrijzer CP; Shao J; Smale ST
Genes Dev; 1996 Apr; 10(7):873-86. PubMed ID: 8846923
[TBL] [Abstract][Full Text] [Related]
26. Unique TATA-binding protein-containing complexes and cofactors involved in transcription by RNA polymerases II and III.
Chiang CM; Ge H; Wang Z; Hoffmann A; Roeder RG
EMBO J; 1993 Jul; 12(7):2749-62. PubMed ID: 7687540
[TBL] [Abstract][Full Text] [Related]
27. The basal transcription factors TBP and TFB from the mesophilic archaeon Methanosarcina mazeii: structure and conformational changes upon interaction with stress-gene promoters.
Thomsen J; De Biase A; Kaczanowski S; Macario AJ; Thomm M; Zielenkiewicz P; MacColl R; Conway de Macario E
J Mol Biol; 2001 Jun; 309(3):589-603. PubMed ID: 11397082
[TBL] [Abstract][Full Text] [Related]
28. Effects of staurosporine on transcription by vesicular stomatitis virus.
Rigaut KD; Gao Y; Lenard J
Virology; 1993 Jun; 194(2):433-40. PubMed ID: 8389071
[TBL] [Abstract][Full Text] [Related]
29. Determinants of serotype specificity in transcription of vesicular stomatitis virus synthetic nucleocapsids.
Smallwood S; Richards-Sumners E; Moyer SA
Virology; 1994 Feb; 199(1):11-9. PubMed ID: 8116233
[TBL] [Abstract][Full Text] [Related]
30. An RNA polymerase II transcription factor inactivated in poliovirus-infected cells copurifies with transcription factor TFIID.
Kliewer S; Dasgupta A
Mol Cell Biol; 1988 Aug; 8(8):3175-82. PubMed ID: 2850483
[TBL] [Abstract][Full Text] [Related]
31. Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter.
Zhou Q; Lieberman PM; Boyer TG; Berk AJ
Genes Dev; 1992 Oct; 6(10):1964-74. PubMed ID: 1398073
[TBL] [Abstract][Full Text] [Related]
32. Transcription sans TBP.
Apone LM; Green MR
Nature; 1998 May; 393(6681):114-5. PubMed ID: 9603513
[No Abstract] [Full Text] [Related]
33. Small-scale density gradient sedimentation to separate and analyze multiprotein complexes.
Tanese N
Methods; 1997 Jul; 12(3):224-34. PubMed ID: 9237167
[TBL] [Abstract][Full Text] [Related]
34. Activity of vesicular stomatitis virus M protein mutants in cell rounding is correlated with the ability to inhibit host gene expression and is not correlated with virus assembly function.
Lyles DS; McKenzie MO
Virology; 1997 Mar; 229(1):77-89. PubMed ID: 9123880
[TBL] [Abstract][Full Text] [Related]
35. Underwinding of DNA on binding of yeast TFIID to the TATA element.
Tabuchi H; Handa H; Hirose S
Biochem Biophys Res Commun; 1993 May; 192(3):1432-8. PubMed ID: 8507207
[TBL] [Abstract][Full Text] [Related]
36. Identification of a minimal set of proteins that is sufficient for accurate initiation of transcription by RNA polymerase II.
Tyree CM; George CP; Lira-DeVito LM; Wampler SL; Dahmus ME; Zawel L; Kadonaga JT
Genes Dev; 1993 Jul; 7(7A):1254-65. PubMed ID: 8319911
[TBL] [Abstract][Full Text] [Related]
37. Promoter analysis of the vesicular stomatitis virus RNA polymerase.
Smallwood S; Moyer SA
Virology; 1993 Jan; 192(1):254-63. PubMed ID: 8390755
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of cell functions by RNA-virus infections.
Kääriäinen L; Ranki M
Annu Rev Microbiol; 1984; 38():91-109. PubMed ID: 6093688
[TBL] [Abstract][Full Text] [Related]
39. A mediator required for activation of RNA polymerase II transcription in vitro.
Flanagan PM; Kelleher RJ; Sayre MH; Tschochner H; Kornberg RD
Nature; 1991 Apr; 350(6317):436-8. PubMed ID: 2011193
[TBL] [Abstract][Full Text] [Related]
40. Chromatin is permissive to TATA-binding protein (TBP)-mediated transcription initiation.
Remboutsika E; Jacq X; Tora L
J Biol Chem; 2001 Apr; 276(16):12781-4. PubMed ID: 11279078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
